Hypoalbuminemia at admission to a PICU is associated with higher 60-day mortality, longer duration of mechanical ventilation, and lower probability of ICU discharge. These associations are independent of the magnitude of inflammatory response, clinical severity, and nutritional status.
Primary hyperoxaluria type 1 (PH1) is a rare autosomal recessive disorder characterised by an increased urinary excretion of calcium oxalate, leading to recurrent urolithiasis, nephrocalcinosis and accumulation of insoluble oxalate throughout the body (oxalosis) when the glomerular filtration rate falls to below 40-20 mL/min per 1.73 m(2). The disease is due to a functional defect of the liver-specific peroxisomal enzyme alanine: glyoxylate aminotransferase (AGT), the gene of which is located on chromosome 2q37.3. The diagnosis is based on increased urinary oxalate and glycollate, increased plasma oxalate and AGT measurement in a liver biopsy. AGT mistargeting may be investigated by immuno-electron microscopy and DNA analysis. End-stage renal failure is reached by the age of 15 years in 50% of PH1 patients and the overall death rate approximates 30%. The conservative treatment includes high fluid intake, pyridoxine and crystallisation inhibitors. Since the kidney is the main target of the disease, isolated kidney transplantation (Tx) has been proposed in association with vigorous peri-operative haemodialysis in an attempt to clear plasma oxalate at the time of Tx. However, because of a 100% recurrence rate, the average 3-year graft survival is 15%-25% in Europe, with a 5-10-year patient survival rate ranging from 10% to 50%. Since the liver is the only organ responsible for the detoxification of glyoxylate by AGT, deficient host liver removal is the first rationale for enzyme replacement therapy. Subsequent orthotopic liver Tx aims to supply the missing enzyme in its normal cellular and subcellular location and thus can be regarded as a form of gene therapy. Because of the usual spectrum of the disease, isolated liver Tx is limited to selected patients prior to having reached an advanced stage of chronic renal failure. Combined liver-kidney Tx has therefore become a conventional treatment for most PH1 patients: according to the European experience, patient survival approximates 80% at 5 years and 70% at 10 years. In addition, the renal function of survivors remains stable over time, between 40 and 60 mL/min per 1.73 m(2) after 5 to 10 years. In addition, liver Tx may allow the reversal of systemic storage disease (i.e. bone, heart, vessels, nerves) and provide valuable quality of life. Whatever the transplant strategy, the outcome is improved when patients are transplanted early in order to limit systemic oxalosis. According to the European experience, it appears that combined liver-kidney Tx is performed in PH1 patients with encouraging results, renal Tx alone has little role in the treatment of this disease, and liver Tx reverses the underlying metabolic defect and its clinical consequences.
OBJETIVO:Avaliar o cumprimento da técnica de lavagem das mãos empregadas em uma unidade de terapia intensiva neonatal (UTIN) pelos profissionais de saúde e visitantes. MÉTODOS: Estudo prospectivo e observacional em uma UTIN universitária em Santos (SP). Observações foram feitas nos períodos da manhã e da tarde por um período de sete meses. Os dados foram coletados por dois estudantes de medicina em planilha específica. As pessoas observadas não sabiam da natureza do trabalho. Para comparar os resultados obsevados entre categorias profissionais e entre períodos de observação, utilizou-se o teste do qui-quadrado ou exato de Fisher, com duas abordagens: a) análise por intenção de tratar (considerando o número total de indivíduos e assumindo que aqueles que não lavaram as mãos adotaram o procedimento incorreto) e b) análise por protocolo (apenas aqueles que lavaram as mãos foram considerados). Rejeitou-se a hipótese de nulidade se p<0,05. RESULTADOS:Foram realizadas 43 observações com duração de cerca de 30 minutos cada uma, sendo 20 minutos durante a manhã e 23 à tarde. Entre as pessoas analisadas, seis (14%) eram médicos, 26 (60%) da equipe de enfermagem, três (7%) técnicos de laboratório e raio X e oito (19%) acompanhantes de pacientes. Dentre os observados, 24 (56%) lavaram as mãos antes de entrar na unidade, sendo a lavagem observada com maior frequência no período da manhã (75%) do que à tarde (39%). A técnica correta não foi observada em nenhuma das vezes. CONCLUSÕES:A técnica de lavagem das mãos raramente é adequada e, por isso, programas educacionais para aumentar a adesão dos profissionais de saúde são importantes.
Renal osteodystrophy is an important problem in children with chronic renal failure, leading to skeletal deformities. The most-frequent type of renal osteodystrophy is secondary hyperparathyroidism, and the main factors contributing to the pathogenesis of this condition are completely or partially corrected after successful renal transplantation. The present paper reviews data on the evolution of secondary hyperparathyroidism after transplantation. Studies in both adults and children suggest that secondary hyperparathyroidism and increased bone remodelling activity may persist months after transplantation. The severity of secondary hyperparathyroidism prior to transplantation, the duration of dialysis, and the development of nodular and/or monoclonal hyperplasia of parathyroid glands are the most-important factors that determine the phenomenon. Important issues, which still need to be answered, are the possible roles of growth factors, cytokines, VDR gene polymorphism (B/b allele), and type of immunosuppressive regimen in the skeletal abnormalities observed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.